Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Transforaminal Lumbar Interbody Fusion Market by Type (Open Surgery, Minimally Invasive Surgery), By Application (Hospital, Clinic, Ambulatory Surgical Center, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Transforaminal Lumbar Interbody Fusion Market by Type (Open Surgery, Minimally Invasive Surgery), By Application (Hospital, Clinic, Ambulatory Surgical Center, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 270362 4200 Medical Care 377 179 Pages 4.8 (39)
                                          

Market Overview:


The global transforaminal lumbar interbody fusion (TLIF) market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of spinal disorders, technological advancements in surgical procedures, and rising demand for minimally invasive surgeries. Based on type, the global TLIF market is segmented into open surgery and minimally invasive surgery. Open surgery dominates the market owing to its high success rate and low cost as compared to other surgical procedures. However, minimally invasive surgery is expected to grow at a higher CAGR during the forecast period due its advantages such as reduced pain and blood loss, shorter hospital stay, and faster recovery time as compared to open surgery. Based on application, hospitals account for majority of the share in the global TLIF market followed by clinics and ambulatory surgical centers (ASCs). Hospitals are expected witness highest growth during 2018-2030 owing rising number of spinal surgeries being performed in this setting coupled with increasing healthcare expenditure across developed countries.


Global Transforaminal Lumbar Interbody Fusion Industry Outlook


Product Definition:


Transforaminal lumbar interbody fusion (TLIF) is a surgical procedure used to fuse two or more vertebrae in the lower back. The surgery is performed through an incision in the back, and screws or other implants are used to hold the vertebrae together while they heal. This procedure may be recommended if you have chronic low back pain that has not responded to other treatments.


Open Surgery:


Open surgery is a type of minimally invasive surgical procedure that makes use of a small incision (usually less than 2 inches) and allows the surgeon to see the entire affected area. Open surgeries are usually performed on an outpatient basis, with no overnight stays in hospitals.


The growth factor for transforaminal lumbar interbody fusion market is mainly driven by factors such as increasing geriatric population base, rising prevalence of spinal disorders & injuries coupled with technological advancements in spine surgery field.


Minimally Invasive Surgery:


Minimally invasive surgery (MIS) is a term used to define surgical procedures where the incisions are small and the recovery time is fast. Minimally invasive surgeries have evolved over recent years due to technological advancements, patient awareness, and acceptance. MIS has several advantages such as it's cost-effective & faster than open surgery; reduces post-operative pain & complications; allows rapid return to normal activities; improves cosmetic results; and provides an extended life expectancy.


Application Insights:


Based on application, the global market is segmented into hospital, clinic or ambulatory surgical center and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high volume of surgeries performed and increasing number of hospitals that offer transforaminal lumbar interbody fusion procedures worldwide. For instance, according to WHO, there are over 1,000 hospitals that perform L4/L5 discectomy every year whereas less than 100 do so annually 10 years ago.


Regional Analysis:


North America dominated the global transforaminal lumbar interbody fusion market in 2016 with a revenue share of over 50%. The growing prevalence of osteoporosis and increasing geriatric population are some factors responsible for the large share. In addition, rising demand for minimally invasive surgeries is also expected to drive growth during the forecast period.


Asia Pacific is anticipated to witness rapid growth over the forecast period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in government initiatives aimed at reducing chronic diseases burden will boost regional product demand during the forecast period. For instance, according to WHO statistics (2017), cardiovascular disease accounts for approximately 13% of deaths in China while diabetes accounts for another 8%. Thus, these factors are expected to boost regional market growth during future years as well.


Growth Factors:


  • Increasing incidence of back pain: The increasing incidence of back pain is one of the key growth drivers for the Transforaminal Lumbar Interbody Fusion market. According to a study by the American Chiropractic Association, around 31 million Americans suffer from low-back pain at any given time. This number is expected to increase in the coming years due to factors such as aging population, obesity, and sedentary lifestyle.
  • Rising demand for minimally invasive surgeries: Minimally invasive surgeries are gaining popularity due to their shorter recovery times and lesser side effects as compared to traditional open surgeries. This is driving the demand for Transforaminal Lumbar Interbody Fusion procedures which are typically performed using minimally invasive techniques.
  • Growing awareness about spinal disorders: There has been a growing awareness about spinal disorders in recent years owing to increasing incidences of spine-related injuries and diseases across all age groups. This is leading more people to seek treatment for their spine problems, thereby boosting the demand for Transforaminal Lumbar Interbody Fusion procedures worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Transforaminal Lumbar Interbody Fusion Market Research Report

By Type

Open Surgery, Minimally Invasive Surgery

By Application

Hospital, Clinic, Ambulatory Surgical Center, Others

By Companies

NuVasive, Zimmer Biomet, Stryker, Ulrich Medical, Cintas, Medtronic

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

179

Number of Tables & Figures

126

Customization Available

Yes, the report can be customized as per your need.


Global Transforaminal Lumbar Interbody Fusion Market Report Segments:

The global Transforaminal Lumbar Interbody Fusion market is segmented on the basis of:

Types

Open Surgery, Minimally Invasive Surgery

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Ambulatory Surgical Center, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. NuVasive
  2. Zimmer Biomet
  3. Stryker
  4. Ulrich Medical
  5. Cintas
  6. Medtronic

Global Transforaminal Lumbar Interbody Fusion Market Overview


Highlights of The Transforaminal Lumbar Interbody Fusion Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Open Surgery
    2. Minimally Invasive Surgery
  1. By Application:

    1. Hospital
    2. Clinic
    3. Ambulatory Surgical Center
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Transforaminal Lumbar Interbody Fusion Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Transforaminal Lumbar Interbody Fusion Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Transforaminal lumbar interbody fusion (TLIF) is a surgical procedure that uses screws, rods, and other hardware to fuse the two ends of the spinal cord. TLIF is used to treat conditions such as low back pain, sciatica, and degenerative disc disease.

Some of the major players in the transforaminal lumbar interbody fusion market are NuVasive, Zimmer Biomet, Stryker, Ulrich Medical, Cintas, Medtronic.

The transforaminal lumbar interbody fusion market is expected to register a CAGR of 5.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transforaminal Lumbar Interbody Fusion Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Transforaminal Lumbar Interbody Fusion Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Transforaminal Lumbar Interbody Fusion Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Transforaminal Lumbar Interbody Fusion Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Transforaminal Lumbar Interbody Fusion Market Size & Forecast, 2018-2028       4.5.1 Transforaminal Lumbar Interbody Fusion Market Size and Y-o-Y Growth       4.5.2 Transforaminal Lumbar Interbody Fusion Market Absolute $ Opportunity

Chapter 5 Global Transforaminal Lumbar Interbody Fusion Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      5.2.1 Open Surgery
      5.2.2 Minimally Invasive Surgery
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Transforaminal Lumbar Interbody Fusion Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinic
      6.2.3 Ambulatory Surgical Center
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Transforaminal Lumbar Interbody Fusion Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Transforaminal Lumbar Interbody Fusion Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Transforaminal Lumbar Interbody Fusion Analysis and Forecast
   9.1 Introduction
   9.2 North America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      9.6.1 Open Surgery
      9.6.2 Minimally Invasive Surgery
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinic
      9.10.3 Ambulatory Surgical Center
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Transforaminal Lumbar Interbody Fusion Analysis and Forecast
   10.1 Introduction
   10.2 Europe Transforaminal Lumbar Interbody Fusion Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      10.6.1 Open Surgery
      10.6.2 Minimally Invasive Surgery
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinic
      10.10.3 Ambulatory Surgical Center
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Transforaminal Lumbar Interbody Fusion Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Transforaminal Lumbar Interbody Fusion Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      11.6.1 Open Surgery
      11.6.2 Minimally Invasive Surgery
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinic
      11.10.3 Ambulatory Surgical Center
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Transforaminal Lumbar Interbody Fusion Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      12.6.1 Open Surgery
      12.6.2 Minimally Invasive Surgery
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinic
      12.10.3 Ambulatory Surgical Center
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Transforaminal Lumbar Interbody Fusion Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Transforaminal Lumbar Interbody Fusion Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Transforaminal Lumbar Interbody Fusion Market Size Forecast by Type
      13.6.1 Open Surgery
      13.6.2 Minimally Invasive Surgery
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Transforaminal Lumbar Interbody Fusion Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinic
      13.10.3 Ambulatory Surgical Center
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Transforaminal Lumbar Interbody Fusion Market: Competitive Dashboard
   14.2 Global Transforaminal Lumbar Interbody Fusion Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 NuVasive
      14.3.2 Zimmer Biomet
      14.3.3 Stryker
      14.3.4 Ulrich Medical
      14.3.5 Cintas
      14.3.6 Medtronic

Our Trusted Clients

Contact Us